Chargement en cours...
Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease
Multicentric Castleman’s disease (MCD) is a rare, widespread lymphoproliferative disorder and a life-threatening disease involving hyperactivity of the immune system, excessive proinflammatory cytokine release, immune cell proliferation, and organ system dysfunction. Interleukin-6 (IL-6) is a cytoki...
Enregistré dans:
| Publié dans: | Patient Relat Outcome Meas |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769562/ https://ncbi.nlm.nih.gov/pubmed/29391839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S140011 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|